Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim Trio 2.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Endoglim Trio 2.2mg Tablet SR

Tridex Met 2.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It aids in regulating blood glucose levels. Tridex Met 2.2mg Extended-Release Tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels and complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are crucial for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, manifested by symptoms such as sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a rapid-acting glucose source like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe renal or hepatic impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Endoglim Trio 2.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Endoglim Trio 2.2mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Endoglim Trio 2.2mg Tablet SR on an empty stomach.

Common Side effects of Endoglim Trio 2.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoglim Trio 2.2mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or fracture it. Consume Endoglim Trio 2.2mg Tablet SR on an empty stomach.

How Endoglim Trio 2.2mg Tablet SR works:

Endoglim Trio SR tablets (2.2mg) contain a triple-action formulation to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Endoglim Trio 2.2mg Tablet SR with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Endoglim Trio 2.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Endoglim Trio 2.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Endoglim Trio 2.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be avoided. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim Trio 2.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Low initial doses are typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Endoglim Trio 2.2mg Tablet SR :

Should you forget a dose of Endoglim Trio 2.2mg SR Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim Trio 2.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Endoglim Trio 2.2mg Tablet SR

Endoglim Trio 2.2mg Extended-Release Tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar elevation. This formulation is unsuitable for type 1 diabetes.
Endoglim Trio 2.2mg Extended-Release Tablets may cause common adverse reactions including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatological eruptions, and upper respiratory infections.
Patients with hypersensitivity to any Endoglim Trio 2.2mg Tablet SR constituent or inactive ingredient should not use this medication. Furthermore, its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Endoglim Trio 2.2mg SR tablets is unsafe. This combination may lead to dangerously low blood sugar and a heightened risk of lactic acidosis.
Indeed, Endoglim Trio 2.2mg Tablet SR can induce hypoglycemia, characterized by low blood sugar. Manifestations of this condition may include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Endoglim Trio 2.2mg Table...
103
MRP 126
18% off